ATPase Inhibitor Factor 1 (ATPIF1) (Soluble Mitochondrial) is a new serum biomarker for metabolism syndrome, cardiovascular research
ATPIF1 is a new Myokine
ATPase inhibitory factor 1 (IF1)
Sample Tested
Features
Size: 96 T Standard Range: 12.5 ~ 3200 pg/mL Sensitivity: 7 pg/mL Specificity: Human Calibration: rh ATPIF1 Rec. Sample Type: serum or plasma Intra-CV: 4 -8 % Inter-CV: 4-9% Data Sheet: PDF
References:
Gore E, et al. The Multifaceted ATPase Inhibitory Factor 1 (IF1) in Energy Metabolism Reprogramming and Mitochondrial Dysfunction: A New Player in Age-Associated Disorders? Antioxid Redox Signal. 2022 Jan 4. doi: 10.1089/ars.2021.0137.
Solaini G, et al. The F1Fo-ATPase inhibitor, IF1, is a critical regulator of energy metabolism in cancer cells. Biochem Soc Trans. 2021 Apr 30;49(2):815-827. doi: 10.1042/BST20200742.
Lee HJ, et al. ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathways. FASEB J. 2019 Dec;33(12):14825-14840
Zhang K, et al. ATP synthase inhibitory factor subunit 1 regulates islet β-cell function via repression of mitochondrial homeostasis. Lab Invest. 2022 Jan;102(1):69-79.
ahancová A, et al. Regulation of glucose-stimulated insulin secretion by ATPase Inhibitory Factor 1 (IF1). FEBS Lett. 2018 Mar;592(6):999-1009.